Fate Therapeutics (FATE) Financials

$2.36

$-0.09 (-3.48%)

As on 10-Sep-2026 10:38EDT

Market cap

$297 Mln

Revenue (TTM)

$6 Mln

P/E Ratio

--

P/B Ratio

1.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	6.49	6.65	13.63	63.53	96.30	55.85
Cost of Revenue	31.82	12.90	118.53	157.19	13.76	5.85
Gross Profit	-22.27	-6.26	-104.90	-93.65	96.30	50.00
Operating Expenses	111.33	141.45	105.38	96.86	404.69	266.99
Operating Profit (EBIT)	-133.59	-147.70	-210.28	-190.51	-308.39	-216.99
Other Income	--	--	--	--	--	4.84
Profit before Tax	-126.00	-136.32	-186.26	-160.93	-281.72	-212.15
Provision for Tax	--	--	--	18.11	-26.67	-5.85
Profit after Tax (Net Income)	-126.00	-136.32	-186.26	-160.93	-255.06	-212.15
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-281.72	-212.15

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	153.44	207.18	318.73	368.42	483.94	678.84
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	74.07	75.68	83.45	98.71	107.57	161.33
Current Liabilities	32.59	36.07	38.52	39.09	114.05	81.28
Total Liabilities	292.70	318.94	440.69	506.22	705.56	921.46

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	102.15	110.23	148.79	174.68	203.49	288.04
Current Assets	157.95	208.70	291.91	331.54	502.07	633.41
Total Assets	292.70	318.94	440.69	506.22	705.56	921.46
Total Debt*	75.68	77.85	85.27	103.54	109.34	114.82
Net Current Assets	125.36	172.63	253.39	292.45	388.02	552.13

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-106.08	-122.87	-132.26	-248.21	-162.87
Cash Flow from Investing Activities	--	111.17	12.22	112.67	166.75	-324.02
Cash from Financing Activities	--	5.49	99.89	0.09	9.21	453.13
Net Cash Inflow / Outflow	--	--	--	--	--	-33.76

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.05	-1.15	-1.58	-1.63	-2.62	-2.21
Cash EPS ($)	--	-1.04	-1.42	-1.45	-2.48	-2.15
Adjusted Book Value ($)	--	1.74	2.71	3.74	4.98	7.09
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.89	-1.04	-1.34	-2.55	-1.70
Free Cash Flow per Share ($)	--	-0.94	-1.05	-1.40	-2.92	-2.23

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-39.57	-42.53	-30.21	-36.78	-33.27
ROE (%)	-69.88	-51.84	-54.21	-37.76	-43.87	-39.90
ROA (%)	-36.36	-35.89	-39.34	-26.56	-31.35	-27.48
EBIT Margin (%)	-1,476.46	-2,051.08	-1,434.52	-253.30	-320.23	-379.89
Net Margin (%)	-1,941.09	-2,051.08	-1,366.46	-253.30	-264.86	-349.57
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	-23.36	-0.51	-0.79	-0.34	0.72	0.78
EBIT Growth (%)	42.40	30.29	-21.51	47.82	-45.36	-65.63
Net Profit Growth (%)	26.54	26.82	-15.74	36.90	-20.22	-22.36
EPS Growth (%)	27.45	0.27	0.03	0.38	-0.18	-0.12
Book Value Growth (%)	-42.20	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.86	-1.04	-2.29	-3.85	-26.42
Price / Book Value	1.89	0.56	0.61	1.00	2.03	8.26
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-2.59	0.07	0.00	-1.10	-2.22	-24.74
Close Price ($)	2.70	0.98	1.65	3.74	10.09	58.51
High Price ($)	2.88	1.99	8.83	11.44	62.03	121.16
Low Price ($)	0.91	0.66	1.55	1.63	9.56	43.60
Market Cap ($ Cr)	297.15	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.38	0.27	0.28	0.23	0.17
Short term debt to equity ratio	0.03	0.02	0.02	0.02	0.01	0.01
Current Ratio	4.85	5.79	7.58	8.48	4.40	7.79
Quick Ratio	4.85	--	--	--	4.40	--
Interest Coverage	--	--	--	--	-52.79	-46.72

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	10.83	13.78	25.96	2.87	39.96	15.54
Asset Turnover	0.02	0.02	0.03	0.10	0.12	0.07
Receivable days	--	122.42	71.88	115.86	89.43	46.41
Inventory Days	--	--	--	0.00	0.00	0.00
Payable days	--	170.17	21.70	15.09	224.03	464.99
Cash Conversion Cycle	--	--	--	100.77	-134.60	-418.58

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.